{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T13:26:36Z","timestamp":1791206796979,"version":"4.1.0"},"reference-count":24,"publisher":"The Endocrine Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,2,1]]},"DOI":"10.1210\/en.2014-1914","type":"journal-article","created":{"date-parts":[[2014,12,2]],"date-time":"2014-12-02T13:15:30Z","timestamp":1417526130000},"page":"548-554","source":"Crossref","is-referenced-by-count":56,"title":["Meclozine Promotes Longitudinal Skeletal Growth in Transgenic Mice with Achondroplasia Carrying a Gain-of-Function Mutation in the FGFR3 Gene"],"prefix":"10.1210","volume":"156","author":[{"given":"Masaki","family":"Matsushita","sequence":"first","affiliation":[{"name":"Division of Neurogenetics, Center for Neurological Diseases and Cancer (M.M., S.H., B.O., A.M., K.O.), Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan"},{"name":"Department of Orthopaedic Surgery (M.M., H.K., N.I.), Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Division of Neurogenetics, Center for Neurological Diseases and Cancer (M.M., S.H., B.O., A.M., K.O.), Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kitoh","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery (M.M., H.K., N.I.), Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensaku","family":"Mori","sequence":"additional","affiliation":[{"name":"Department of Media Science (K.M.), Graduate School of Information Science, Nagoya University, Nagoya 466-8550, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bisei","family":"Ohkawara","sequence":"additional","affiliation":[{"name":"Division of Neurogenetics, Center for Neurological Diseases and Cancer (M.M., S.H., B.O., A.M., K.O.), Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Yasoda","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Nutrition (A.Y.), Kyoto University Graduate School of Medicine, Kyoto 606-8501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Masuda","sequence":"additional","affiliation":[{"name":"Division of Neurogenetics, Center for Neurological Diseases and Cancer (M.M., S.H., B.O., A.M., K.O.), Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Ishiguro","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery (M.M., H.K., N.I.), Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinji","family":"Ohno","sequence":"additional","affiliation":[{"name":"Division of Neurogenetics, Center for Neurological Diseases and Cancer (M.M., S.H., B.O., A.M., K.O.), Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2014,12,2]]},"reference":[{"key":"2019041119495472100_B1","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/371252a0","article-title":"Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia","volume":"371","author":"Rousseau","year":"1994","journal-title":"Nature"},{"key":"2019041119495472100_B2","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0092-8674(94)90302-6","article-title":"Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia","volume":"78","author":"Shiang","year":"1994","journal-title":"Cell"},{"key":"2019041119495472100_B3","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1093\/hmg\/4.11.2097","article-title":"A common FGFR3 gene mutation in hypochondroplasia","volume":"4","author":"Prinos","year":"1995","journal-title":"Hum Mol Genet"},{"key":"2019041119495472100_B4","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1086\/302275","article-title":"A novel skeletal dysplasia with developmental delay and acanthosis nigricans is caused by a Lys650Met mutation in the fibroblast growth factor receptor 3 gene","volume":"64","author":"Tavormina","year":"1999","journal-title":"Am J Hum Genet"},{"key":"2019041119495472100_B5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/ng0395-321","article-title":"Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3","volume":"9","author":"Tavormina","year":"1995","journal-title":"Nat Genet"},{"key":"2019041119495472100_B6","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1086\/508433","article-title":"A novel mutation in FGFR3 causes camptodactyly, tall stature, and hearing loss (CATSHL) syndrome","volume":"79","author":"Toydemir","year":"2006","journal-title":"Am J Hum Genet"},{"key":"2019041119495472100_B7","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1002\/ajmg.a.32485","article-title":"The population-based prevalence of achondroplasia and thanatophoric dysplasia in selected regions of the US","volume":"146A","author":"Waller","year":"2008","journal-title":"Am J Med Genet A"},{"key":"2019041119495472100_B8","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0140-6736(07)61090-3","article-title":"Achondroplasia","volume":"370","author":"Horton","year":"2007","journal-title":"Lancet"},{"key":"2019041119495472100_B9","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/ajmg.1320420508","article-title":"Growth hormone therapy in achondroplasia","volume":"42","author":"Horton","year":"1992","journal-title":"Am J Med Genet"},{"key":"2019041119495472100_B10","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2106\/00004623-199806000-00003","article-title":"Distraction osteogenesis of the lower extremity with use of monolateral external fixation. A study of two hundred and sixty-one femora and tibiae","volume":"80","author":"Noonan","year":"1998","journal-title":"J Bone Joint Surg Am"},{"key":"2019041119495472100_B11","doi-asserted-by":"crossref","first-page":"20644","DOI":"10.1074\/jbc.M109.083626","article-title":"NF449 is a novel inhibitor of fibroblast growth factor receptor 3 (FGFR3) signaling active in chondrocytes and multiple myeloma cells","volume":"285","author":"Krejci","year":"2010","journal-title":"J Biol Chem"},{"key":"2019041119495472100_B12","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/hmg\/ddr514","article-title":"A novel tyrosine kinase inhibitor restores chondrocyte differentiation and promotes bone growth in a gain-of-function Fgfr3 mouse model","volume":"21","author":"Jonquoy","year":"2012","journal-title":"Hum Mol Genet"},{"key":"2019041119495472100_B13","doi-asserted-by":"crossref","first-page":"5443","DOI":"10.1093\/hmg\/dds390","article-title":"A novel FGFR3-binding peptide inhibits FGFR3 signaling and reverses the lethal phenotype of mice mimicking human thanatophoric dysplasia","volume":"21","author":"Jin","year":"2012","journal-title":"Hum Mol Genet"},{"key":"2019041119495472100_B14","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/nm971","article-title":"Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway","volume":"10","author":"Yasoda","year":"2004","journal-title":"Nat Med"},{"key":"2019041119495472100_B15","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1210\/en.2008-1676","article-title":"Systemic administration of C-type natriuretic peptide as a novel therapeutic strategy for skeletal dysplasias","volume":"150","author":"Yasoda","year":"2009","journal-title":"Endocrinology"},{"key":"2019041119495472100_B16","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.ajhg.2012.10.014","article-title":"Evaluation of the therapeutic potential of a CNP analog in a Fgfr3 mouse model recapitulating achondroplasia","volume":"91","author":"Lorget","year":"2012","journal-title":"Am J Hum Genet"},{"key":"2019041119495472100_B17","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nature13775","article-title":"Statin treatment rescues FGFR3 skeletal dysplasia phenotypes","volume":"513","author":"Yamashita","year":"2014","journal-title":"Nature"},{"key":"2019041119495472100_B18","doi-asserted-by":"crossref","first-page":"e81569","DOI":"10.1371\/journal.pone.0081569","article-title":"Meclozine facilitates proliferation and differentiation of chondrocytes by attenuating abnormally activated FGFR3 signaling in achondroplasia","volume":"8","author":"Matsushita","year":"2013","journal-title":"PLoS One"},{"key":"2019041119495472100_B19","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.1242\/dev.125.24.4977","article-title":"Repression of hedgehog signaling and BMP4 expression in growth plate cartilage by fibroblast growth factor receptor 3","volume":"125","author":"Naski","year":"1998","journal-title":"Development"},{"key":"2019041119495472100_B20","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1117\/12.480417","article-title":"Fast software-based volume rendering using multimedia instructions on PC platforms and its application to virtual endoscopy","volume":"5031","author":"Mori","year":"2003","journal-title":"Proc SPIE"},{"key":"2019041119495472100_B21","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1242\/dev.120.5.1109","article-title":"The role of Pax-1 in axial skeleton development","volume":"120","author":"Wallin","year":"1994","journal-title":"Development"},{"key":"2019041119495472100_B22","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1177\/0091270011414575","article-title":"Meclizine metabolism and pharmacokinetics: Formulation on its absorption","volume":"52","author":"Wang","year":"2012","journal-title":"J Clin Pharmacol"},{"key":"2019041119495472100_B23","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/BPO.0b013e318093f523","article-title":"Distraction osteogenesis of the lower extremity in patients with achondroplasia\/hypochondroplasia treated with transplantation of culture-expanded bone marrow cells and platelet-rich plasma","volume":"27","author":"Kitoh","year":"2007","journal-title":"J Pediatr Orthop B"},{"key":"2019041119495472100_B24","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/hmg\/ddn339","article-title":"FGFR3 promotes synchondrosis closure and fusion of ossification centers through the MAPK pathway","volume":"18","author":"Matsushita","year":"2009","journal-title":"Hum Mol Genet"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/156\/2\/548\/8989945\/endo0548.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,23]],"date-time":"2022-04-23T14:53:41Z","timestamp":1650725621000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/156\/2\/548\/2422492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,2]]},"references-count":24,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,12,2]]},"published-print":{"date-parts":[[2015,2,1]]}},"URL":"https:\/\/doi.org\/10.1210\/en.2014-1914","relation":{},"ISSN":["0013-7227","1945-7170"],"issn-type":[{"value":"0013-7227","type":"print"},{"value":"1945-7170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,2]]}}}